SEC Form 5 · accession 0001387131-16-004225
Adamis Pharmaceuticals Corp · ADMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David J. Marguglio
Officer — Senior Vice President · Director
Period of report
Dec 31, 2015
Accepted (ET)
Feb 12, 2016 · 6:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000887247
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 2, 2015 | G | 5,884 | $0.00 | D | 130,227 | D | |
| Common Stock | Apr 2, 2015 | G | 5,884 | $0.00 | A | 5,884 | I | By D. Marguglio as custodian for children |
| Common Stock | Dec 30, 2015 | G | 9,000 | $0.00 | D | 130,227 | D |
Table II — derivative securities
No Table II lines on this filing.